Genivent NR LP is a private equity fund based in Calgary, Alberta, Canada. According to its most recent Form D, filed May 28, 2026, it has sold $2,120,000 of interests to 2 investors since its first sale in Feb 2026. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Barclay Laughland; Matthew Barr; Stephen Johnston.
- Total raised
- $2,120,000Cumulative sales reported on Form D
- Investors
- 2
- First sale
- Feb 25, 2026
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Barclay Laughland; Matthew Barr; Stephen Johnston
- Latest Form D
- May 28, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Genivent NR LP
What is the minimum investment for Genivent NR LP?
Genivent NR LP's latest Form D, filed May 28, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Genivent NR LP?
Genivent NR LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Genivent NR LP raised?
Genivent NR LP reports $2,120,000 sold from 2 investors on its Form D filed May 28, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Genivent NR LP based?
Genivent NR LP is based in Calgary, Alberta, Canada.
When did Genivent NR LP launch?
Genivent NR LP reports its first sale in Feb 2026, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every private equity fund
Raised more than 20% of the 5 private equity funds based in Alberta, Canada, and more than 27% of all 9,159 that report sales.